Codeine

Codeine Is a Controlled Opioid, Not an Unrestricted Pain Pill

Codeine is an opioid medicine used in selected prescription products for pain and, in some formulations, cough. Codeine sulfate tablets are indicated for mild to moderate pain when an opioid is appropriate and alternatives are inadequate. Combination products may contain acetaminophen or another ingredient and have different labeling, dose limits and risks.

Codeine can cause addiction, misuse, life-threatening respiratory depression and fatal overdose. It must not be marketed as available “without prescription.” A patient needs product-specific directions because codeine sulfate is not interchangeable with acetaminophen-codeine tablets, cough liquid or any other formulation.

Controlled-substance scheduling can differ by product and codeine concentration. Pure codeine products and combinations may fall into different U.S. schedules. The pharmacy label for the exact dispensed medicine is the authoritative source.

The First Question Is Whether an Opioid Is Necessary

Pain severity alone does not establish that codeine is the best treatment. A clinician considers the cause and duration of pain, function, prior treatment, respiratory health, other sedatives, substance-use history and non-opioid options. Current opioid labeling emphasizes reserving opioid analgesics for situations in which alternatives are inadequate.

A treatment goal should describe meaningful improvement in function as well as pain. Continued exposure without useful benefit increases risk. If pain is new, rapidly worsening, associated with weakness or numbness, caused by major trauma or accompanied by fever or loss of bladder control, urgent assessment may be needed.

Codeine Must Be Converted to Morphine to Produce Much of Its Effect

The CYP2D6 enzyme converts codeine into morphine. Genetic differences can make this conversion unusually rapid or poor. An ultra-rapid metabolizer can develop unexpectedly high morphine exposure and life-threatening respiratory depression, while a poor metabolizer may obtain little analgesic benefit.

This variability makes self-adjustment particularly unsafe. Taking more because a first dose seems ineffective can be dangerous, and a genetic risk is not visible from body size or previous use.

Children, Adolescents and Breastfeeding Require Strict Safeguards

Codeine is contraindicated in children younger than 12 years and for postoperative pain after tonsil or adenoid surgery in people younger than 18 years under current U.S. opioid labeling. Certain adolescents with conditions that increase breathing risk should also avoid codeine.

Breastfeeding is not recommended during codeine treatment because morphine exposure through breast milk can cause excess sleepiness and serious breathing problems in an infant. Pregnancy exposure, especially prolonged opioid use, can cause neonatal opioid withdrawal syndrome and requires coordinated obstetric and neonatal care.

A pregnant patient should not abruptly stop regular opioid use without medical advice. Maternal withdrawal and uncontrolled pain also require clinical management.

Life-Threatening Respiratory Depression Can Occur

Serious, life-threatening or fatal respiratory depression can occur with codeine, especially when treatment begins, the dose changes or another depressant is added. Older adults and people with chronic lung disease, sleep apnea, reduced respiratory reserve or frailty may be more vulnerable.

• Slow, shallow, irregular or stopped breathing.
• Extreme sleepiness or inability to wake.
• Blue, gray or pale lips and skin.
• Pinpoint pupils, choking or gurgling sounds.
• Collapse or severe confusion.

Call emergency services immediately. Administer naloxone when available and indicated, then continue to follow emergency instructions. Naloxone may wear off before the opioid, so the person still needs medical care even if they wake.

Naloxone Should Be Part of the Safety Conversation

Patients and household members should know how to recognize opioid overdose and how to access and use naloxone. A prescriber may recommend naloxone based on the medicine, dose, other depressants, breathing risk or household exposure.

Store naloxone where others can reach it, check the expiration date and teach family or caregivers how to respond. Do not keep it locked in the same place as the opioid if that would delay access during an emergency.

Alcohol, Benzodiazepines and Sedatives Multiply the Risk

Combining codeine with alprazolam, lorazepam, diazepam or another benzodiazepine can cause profound sedation, respiratory depression, coma and death. Alcohol, zolpidem and other sleep drugs, muscle relaxants, gabapentin, pregabalin, sedating antihistamines, antipsychotics and other opioids can add similar danger.

A cough or pain product may already contain an opioid or acetaminophen. Review the full ingredient list before taking any nonprescription medicine. Do not use alcohol to improve pain relief or sleep.

Acetaminophen-Codeine Products Have an Additional Liver Risk

When codeine is combined with acetaminophen, the daily total from every product matters. Cold, flu, headache and sleep products may also contain acetaminophen. Excess exposure can cause severe liver injury, transplant or death.

The “300/30 mg” notation commonly means 300 mg acetaminophen with 30 mg codeine, not 300 mg of codeine. A product description must identify both ingredients. Do not use a codeine-only dosing statement for a combination tablet.

Ask the pharmacist to calculate the total acetaminophen exposure from all products. People with liver disease or regular alcohol use need particular caution.

Abuse, Addiction and Accidental Ingestion

Codeine exposes patients and other household members to opioid addiction, abuse and misuse. Risk should be assessed before treatment and monitored throughout use. Taking extra tablets, using the medicine for emotional distress, crushing or altering a product, sharing it or obtaining it from several sources are danger signs.

Even one accidental ingestion can be fatal to a child. Store codeine securely and immediately return the container after each use. Never leave a dose on a counter, in a bag or at the bedside where another person can reach it.

Physical Dependence and Withdrawal

Physical dependence can develop during ongoing opioid treatment. Abrupt discontinuation may cause restlessness, sweating, runny nose, yawning, abdominal cramping, diarrhea, nausea, insomnia, anxiety and pain. Withdrawal is distressing and can destabilize medical or mental health.

A clinician should create a patient-specific taper when reduction is appropriate. Do not cut an extended-release product, switch formulations or use illicit opioids to manage withdrawal. Patients who show opioid-use-disorder symptoms should be offered evidence-based treatment rather than abruptly dismissed from care.

Common Effects and Everyday Injury Prevention

Codeine can cause constipation, nausea, vomiting, dizziness, drowsiness, itching and sweating. It can impair judgment and motor skills. Do not drive or operate machinery until the individual response is known and the prescriber has addressed other sedatives.

• Discuss a constipation-prevention plan at the start of treatment.
• Rise slowly to reduce dizziness and falls.
• Report severe abdominal swelling or inability to pass stool.
• Seek care for facial swelling, wheezing or serious rash.
• Do not use an extra dose for breakthrough pain without instructions.

Important Drug-Metabolism Interactions

Medicines that inhibit or induce CYP2D6 or CYP3A4 can change codeine or morphine exposure. Starting or stopping an interacting medicine may reduce pain relief, intensify toxicity or trigger withdrawal. Serotonergic medicines can also create concern for serotonin syndrome with opioids.

Provide the prescriber and pharmacist with all antidepressants, antifungals, antibiotics, seizure medicines, HIV medicines, sedatives, supplements and recreational substances. Interaction management is product-specific and should not be based on a short list alone.

When Codeine Does Not Control Pain

Poor relief may reflect the type of pain, inadequate diagnosis, a product mismatch, tolerance, CYP2D6 variation or disease progression. Increasing codeine without assessment can increase toxicity and may not improve pain.

1. Do not take an early or double dose.
2. Confirm the exact formulation and label directions.
3. Review whether acetaminophen or another ingredient is included.
4. Record pain, function, sedation and timing.
5. Contact the prescriber to reassess the treatment strategy.

Severe sedation, confusion or slowed breathing is not a sign that the medicine is “working strongly”; it is a potential emergency.

Refill Monitoring and Safer Long-Term Pain Care

A refill review should examine pain-related function, adverse effects, other controlled medicines, substance use, naloxone access and whether codeine remains necessary. Urine or prescription-monitoring checks may be part of responsible care depending on the setting.

Non-opioid medicines, physical therapy, activity pacing, behavioral pain strategies, procedures or treatment of the underlying condition may reduce opioid exposure. The plan should be individualized rather than framed as a promise of zero pain.

Online Codeine Prescriptions Require Extra Verification

A legitimate online service does not sell codeine before a clinician assesses the patient. Controlled-substance prescribing must comply with applicable law, and the pharmacy must be licensed to dispense to the patient’s location.

• Reject “codeine without prescription” offers.
• Verify the pharmacy with an official board of pharmacy.
• Confirm a pharmacist is available for counseling.
• Expect tamper-evident packaging and a patient-specific label.
• Avoid loose tablets and unknown international fulfillment.

Counterfeit opioid tablets may contain fentanyl or another unexpected drug. An imprint match is not enough to prove authenticity.

Storage, Disposal and Household Safety

Keep codeine in its original labeled container in a secure location. Track quantities when appropriate, and do not disclose the storage location unnecessarily. Keep naloxone accessible to a responder.

Use an authorized take-back program for unused medicine. If a take-back option is not readily available, follow current FDA or pharmacy disposal instructions for the exact product. Never share leftovers.

Constipation Prevention Should Start with the Prescription

Opioid constipation can begin quickly and may persist because tolerance to this effect is incomplete. Ask about fluid intake, activity, diet, bowel history and other constipating medicines. The clinician or pharmacist may recommend a bowel regimen based on health and the expected treatment duration.

Severe abdominal pain, persistent vomiting, marked swelling or inability to pass stool or gas needs prompt assessment. Do not repeatedly add laxatives when obstruction is possible.

Nausea and constipation should be tracked separately from pain relief. A medicine that creates major gastrointestinal harm without functional benefit should be reassessed.

Serotonin Syndrome, Adrenal Problems and Hormonal Effects

Opioids can contribute to serotonin syndrome when combined with serotonergic medicines. Warning signs may include agitation, confusion, fever, sweating, tremor, muscle rigidity, diarrhea and rapid heart rate. Seek urgent medical help for a concerning cluster of symptoms.

Longer opioid exposure can affect endocrine function, including sex hormones, and rare adrenal insufficiency has been reported. Persistent fatigue, weakness, dizziness, loss of appetite, nausea or low blood pressure deserves medical evaluation rather than an automatic dose increase.

These symptoms have many possible causes, so diagnosis should be clinical. Do not start hormone or steroid products based on a webpage.

Codeine and Cough Require Product-Specific Caution

Not every codeine product is approved for the same age group or purpose. A pain tablet should not be used as a cough medicine, and a cough liquid can contain additional active ingredients. Household spoons are not accurate measuring devices for liquid medicine.

Persistent cough can reflect asthma, infection, reflux, medication effects or another condition. Cough with breathing difficulty, blue lips, coughing blood, chest pain or significant fever requires evaluation rather than suppression with an online opioid.

A Lost or Early Refill Is a Safety Event

A lost opioid prescription or supply should be handled through the prescriber and pharmacy policy. Replacing it from an online seller can create duplicate exposure, counterfeit risk and legal problems. A clinician may review storage, misuse, diversion or uncontrolled pain before deciding what to do.

Patients should be able to report problems without stigma. Responsible monitoring is intended to keep treatment safe and to identify opioid use disorder early.

Frequently Asked Questions About Codeine

What is codeine used for?

Codeine appears in prescription products for selected pain conditions and, in some formulations, cough. The exact indication depends on the product.

Is codeine an opioid?

Yes. It is an opioid with risks of addiction, respiratory depression, overdose and death.

Can codeine be purchased without a prescription?

BeonMed should not offer prescription codeine without a valid prescription. Laws and scheduling vary by product and location.

Is codeine sulfate the same as acetaminophen with codeine?

No. One contains codeine alone and the other contains two active ingredients with additional acetaminophen limits and liver risk.

What does codeine 300/30 mean?

It commonly refers to 300 mg acetaminophen plus 30 mg codeine, not 300 mg codeine.

Why does CYP2D6 matter?

CYP2D6 converts codeine to morphine. Genetic differences can cause unexpectedly high toxicity or poor pain relief.

Can children take codeine?

Current U.S. labeling includes strict pediatric contraindications, including children under 12 and post-tonsil/adenoid surgery use under 18.

Can codeine be used while breastfeeding?

Breastfeeding is not recommended during codeine treatment because of the risk of excess infant morphine exposure and breathing suppression.

Can codeine be taken with Xanax or Ativan?

The combination can cause profound sedation, respiratory depression, coma and death and requires strict clinical justification.

Can I drink alcohol with codeine?

No. Alcohol can greatly increase sedation, breathing suppression, overdose and, with acetaminophen products, liver risk.

What are codeine overdose signs?

Slow or stopped breathing, inability to wake, pinpoint pupils, bluish lips and collapse require emergency care.

What does naloxone do?

Naloxone can temporarily reverse opioid overdose. Give it as directed and call emergency services because repeat treatment may be needed.

Can codeine cause constipation?

Yes. Constipation is common and should be addressed proactively with the clinician or pharmacist.

Can codeine cause dependence?

Yes. Physical dependence can occur with repeated use, and abrupt stopping can cause withdrawal.

What if codeine does not relieve pain?

Do not increase it. The prescriber should reassess the pain, formulation, metabolism and alternatives.

Can a codeine tablet be split or crushed?

Only when the exact product label and pharmacist permit it. Altering some formulations can be dangerous.

How can counterfeit codeine be avoided?

Use a valid prescription and verified licensed pharmacy. Never buy loose tablets from a marketplace or social account.

How should unused codeine be discarded?

Use an authorized take-back option or follow current FDA and pharmacy instructions for that exact product.

Medical and Regulatory References

• DailyMed: Codeine sulfate tablets
• DailyMed: Acetaminophen and codeine tablets
• FDA: Opioid medications
• FDA: Disposal of unused medicines

Medical disclaimer: This material is educational and cannot identify the correct codeine formulation or dose for an individual. Use only the product dispensed for the named patient and seek emergency help immediately for suspected overdose or breathing suppression.